Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zao Jiao Tong Luo is a Traditional Chinese Medicine (TCM) formulation, most commonly encountered as Zao Jiao Tong Luo capsules, used primarily for the treatment of ischemic stroke and cerebral infarction. The preparation is designed to address the TCM patterns of "phlegm-stasis blocking the collaterals," aiming to improve neurological function and physical disability during the recovery phase of a stroke. Its pharmacological activity is attributed to a combination of herbal and animal-derived components, such as *Gleditsia sinensis* and *Hirudo* (leech). These ingredients work synergistically to inhibit platelet aggregation, promote fibrinolysis, and reduce blood viscosity, thereby improving cerebral microcirculation. Additionally, the formulation exhibits neuroprotective effects by modulating inflammatory pathways and reducing oxidative damage in brain tissues.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zao Jiao Tong Luo.